PETRALIA, GIUSEPPE
PETRALIA, GIUSEPPE
Dipartimento di Oncologia ed Emato-Oncologia
[18F]FDG positron emission tomography/computed tomography and multidetector computed tomography roles in thymic lesion treatment planning
2008-09-01 L .L. Travaini, G. Petralia, G. Trifirò, L. Ravasi, D. Galetta, G. Carbone, F. Falcini, L. Spaggiari, M. Bellomi, G. Paganelli
Active surveillance for prostate cancer: comparison between incidental tumors vs. tumors diagnosed at prostate biopsies
2021-01-01 S. Luzzago, M.L. Piccinelli, G. Marvaso, E. Laukhtina, N. Miura, V.M. Schuettfort, K. Mori, A. Aydh, M. Ferro, F.A. Mistretta, N. Fusco, G. Petralia, B.A. Jereczek-Fossa, S.F. Shariat, P.I. Karakiewicz, O. de Cobelli, G. Musi
The added value of whole-body magnetic resonance imaging in the management of patients with advanced breast cancer
2018-10-01 F. Zugni, F. Ruju, P. Pricolo, S. Alessi, M. Iorfida, M.A. Colleoni, M. Bellomi, G. Petralia
Anterior prostatic tumours are difficult to diagnose without MRI
2012-01-01 G. Petralia, S. Alessi, A. Alconchel, P. Summers, G. Musi, V. Matei, O. de Cobelli, G. Renne, M. Bellomi
Apparent Diffusion Coefficient and Other Preoperative Magnetic Resonance Imaging Features for the Prediction of Positive Surgical Margins in Prostate Cancer Patients Undergoing Radical Prostatectomy
2021-01-01 S. Alessi, R. Maggioni, S. Luzzago, A. Colombo, P. Pricolo, P.E. Summers, G. Saia, M. Manzoni, G. Renne, G. Marvaso, O. De Cobelli, M. Bellomi, B.A. Jereczek-Fossa, G. Petralia
Baseline Multiparametric MRI for Selection of Prostate Cancer Patients Suitable for Active Surveillance : Which Features Matter?
2018-01-01 F. Sanguedolce, G. Petralia, H. Sokhi, E. Tagliabue, N. Anyamene, G. Hellawell, A.R. Padhani
Breast MR with special focus on DW-MRI and DCE-MRI
2011-01-01 G. Petralia, L. Bonello, F. Priolo, P. Summers, M. Bellomi
Capecitabine initially concomitant to radiotherapy then perioperatively administered in locally advanced rectal cancer
2009-01-01 M.C. Zampino, E. Magni, M.C. Leonardi, E. Petazzi, L. Santoro, F. Luca, A. Chiappa, G. Petralia, C. Trovato, N. Fazio, R. Orecchia, F. Nolè, F. de Braud
Clinical evaluation and disease management of PI-RADS 3 lesions. Analysis from a single tertiary high-volume center
2020-09-02 E. Di Trapani, G. Musi, M. Ferro, G. Cordima, F.A. Mistretta, S. Luzzago, R. Bianchi, G. Cozzi, S. Alessi, M. Catellani, D.V. Matei, B.A. Jereczek-Fossa, G. Petralia, O. De Cobelli
Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging facilitates detection of metastases in normal-sized pelvic lymph nodes of patients with bladder and prostate cancer
2013-01-01 F.D. Birkhäuser, U.E. Studer, J.M. Froehlich, M. Triantafyllou, L.J. Bains, G. Petralia, P. Vermathen, A. Fleischmann, H.C. Thoeny
Comparison of whole-body diffusion-weighted magnetic resonance and FDG-PET/CT in the assessment of Hodgkin's lymphoma for staging and treatment response
2014-01-01 J. Montoro, D. Laszlo, N.P.C. Zing, G. Petralia, G. Conte, M. Colandrea, G. Martinelli, L. Preda
Concurrent cisplatin, continuous infusion fluorouracil and radiotherapy followed by tailored consolidation treatment in non metastatic anal squamous cell carcinoma
2011-02-03 M.G. Zampino, E. Magni, M.C. Leonardi, L. Santoro, E. Petazzi, C. Fodor, G. Petralia, C. Trovato, F. Nolè, R. Orecchia
Confirmatory multiparametric magnetic resonance imaging at recruitment confers prolonged stay in active surveillance and decreases the rate of upgrading at follow-up
2019-01-01 S. Luzzago, M. Catellani, E. Di Trapani, G. Cozzi, F.A. Mistretta, R. Bianchi, P. Pricolo, A. Conti, E. Ancona, N. Piacentini, S. Alessi, G. Renne, M. Ferro, D.V. Matei, G. Musi, B. Alicja Jereczek-Fossa, G. Petralia, O. de Cobelli
Contrast-enhanced ultrasound sonography optimises the assessment of lymph nodes in oncology
2013-06-26 G. Petralia, G. Conte, E. De Fiori, S. Alessi, M. Bellomi
Correction: Confirmatory multiparametric magnetic resonance imaging at recruitment confers prolonged stay in active surveillance and decreases the rate of upgrading at follow-up (Prostate Cancer and Prostatic Diseases, (2020), 23, 1, (94-101), 10.1038/s41391-019-0160-3)
2020-03-01 S. Luzzago, M. Catellani, E. Di Trapani, G. Cozzi, F.A. Mistretta, R. Bianchi, P. Pricolo, A. Conti, E. Ancona, N. Piacentini, S. Alessi, G. Renne, M. Ferro, D.-. Matei, G. Musi, B.A. Jereczek-Fossa, G. Petralia, O. de Cobelli
Correlation between CT perfusion and clinico-pathological features in prostate cancer: a prospective study
2015-01-13 E. Łuczyńska, S. Heinze Paluchowska, P. Blecharz, B. Jereczek-Fossa, G. Petralia, M. Bellomi, A. Stelmach
Correlation between radiological and biological features and clinical outcomes in early prostate cancer: an exploratory subgroup analysis
2022-01-12 G. Corrao, G. Marvaso, M. Zaffaroni, S. Volpe, M. Augugliaro, C.I. Fodor, D. Zerini, A. Vingiani, F.A. Mistretta, S. Luzzago, S. Alessi, P. Pricolo, G. Musi, O. De Cobelli, G. Renne, M. Manzoni, G. Petralia, R. Orecchia, B.A. Jereczek-Fossa
CT perfusion for the monitoring of neoadjuvant chemotherapy and radiation therapy in rectal carcinoma : initial experience
2007-08-01 M. Bellomi, G. Petralia, A. Sonzogni, M.G. Zampino, A. Rocca
CT perfusion in oncology: how to do it
2010-02-11 G. Petralia, L. Bonello, S. Viotti, L. Preda, G. d'Andrea, M. Bellomi
CT perfusion in solid-body tumours. Part I: technical issues
2010-02-23 G. Petralia, L. Preda, G. D'Andrea, S. Viotti, L. Bonello, R. De Filippi, M. Bellomi